Upload
naimesh-patel
View
219
Download
0
Embed Size (px)
Citation preview
8/7/2019 First Presentation of M.Pharm
1/34
Naimesh N Patel
M.Pharm Sem-PharmaceuticsKBIPER
8/7/2019 First Presentation of M.Pharm
2/34
Content : -y D efine Biotechnology.y Major Types of Nucleic Acid in Cell.y Why do we need Isolated Pure D NA & RNA?y Methods for Isolation & Purification of D NA.y Method for Isolation & Purification of RNA.y
Method for Isolation of Specifically mRNA.
8/7/2019 First Presentation of M.Pharm
3/34
BIOTECHNOLOGYy F usion of two words : -
y Biologicaly Technology
y It refers to as a link between the biological science,physical science, chemical science and technologicalachievement, commonly reffered as the clever science
of biology.y Various basic biological disciplines involved in the
origin of biotechnology are : -
8/7/2019 First Presentation of M.Pharm
4/34
BIOTECHNOLOGY
Genetics
Engineering technology
Biophysics
Molecular biology
Biochemistry
Cell biology
Microbiology
8/7/2019 First Presentation of M.Pharm
5/34
Maj or Typ es of Nucleic Acid
y
D eoxyribonucleic acid( D NA)y Ribonucleic acid(RNA)
8/7/2019 First Presentation of M.Pharm
6/34
The Central D ogma of Genetics
ReplicationTranscription
Translation
mRNA
non-coding RNA (rRNA, tRNA, siRNA, etc.)
8/7/2019 First Presentation of M.Pharm
7/34
Wh y do we need to isol a ted p ure DNA?
D etect, enumerate species
D etect, enumerate, clone genesD etect/sequence specific D NA regionsCreate new D NA constructs (recombinant D NA)
8/7/2019 First Presentation of M.Pharm
8/34
Th e p urific a tion of nucleic acids bro adly involves following st ages : -
y Breaking or opening of the cells to expose nucleic acid.y Inactivation of D NA- and RNA-degrading enzymes
(D Nases, RNases)y Separation of nucleic acids from cellular components.
y Extraction/Precipitation Methodsy Adsorption Chromatography Method
y Recovery of nucleic acids in a pure form.
8/7/2019 First Presentation of M.Pharm
9/34
1. Bre ak ing or Lysis of cells
a) Bacterial cellsb) Animal cellsc) Plant cells
8/7/2019 First Presentation of M.Pharm
10/34
1. Bre ak ing or Lysis of cells(cont )
a) Bacterial cells : -
The bacterial cells (e.g. E.coli) can be lysed by
combination of enzymatic and chemical treatments.The enzyme lysozyme and the chemical ethylenediaminetetraacetate(E D TA) are used for this purpose.This is followed by the addition of detergent such as
sodium dodecyl sulfate(S D S).
8/7/2019 First Presentation of M.Pharm
11/34
1. Bre ak ing or Lysis of cells(cont )
b) Animal cells : -Animal cells, paticularly cultured animal cells, can be
easily opened by direct treatment of cells with
detergent(S D S).
c) Plant cells : -Plant cells with strong cell walls require harsh
treatment to break open. The cells are frozen and thenground in a mortar and pestle. This is an effective way of breaking the cellulose walls.
8/7/2019 First Presentation of M.Pharm
12/34
2 .S e p a ra tion of DNA from cellul a r com p a rtment
A) Extraction/Precipitation MethodI. Purification of D NA by removing cellular compartmentII. D irect purification of D NA
B) Adsorption Chromatography Method
8/7/2019 First Presentation of M.Pharm
13/34
A) PRECIPITATION METHOD
I. Purification of D NA by Removing Cellular Components:-
y The cellular extract is centrifused at a low speed to remove thedebris(e.g. pieces of cell wall) that forms a pellet at the bottom of thetube.
y The supernatant is collected and treated with phenol to precipitateprotien at the interface between the organic and aqueous layers.
y The aqueous layer, containing the dissolved nucleic acid, is collectedand treated with the enzyme ribonuclease(RNase).
y The RNA is degraded while the D NA remain intact.y This D NA can be precipitated by adding ethanol and isolated after
centrifugation, and suspended in an appropiate buffer.
8/7/2019 First Presentation of M.Pharm
14/34
A) PRECIPITATION METHOD(Cont )II. D irect Purification of D NA y In this approach ,the D NA itself is selectively removed from the
cellular extract and isolated.y In this method, the addition of detergent cetyltrimethyl ammonium
bromide(CTAB) results in the formation of an insoluble complexwith nucleic acid.
y This complex, in the form of a precipitate is collected aftercentrifugation and suspended in a high-salt solution to releasenucleic acids.
y By treatment with RNase, RNA is degraded.y Pure D NA can be isolated by ethanol precipitation.
8/7/2019 First Presentation of M.Pharm
15/34
Overview of the Extraction/Precipitation Method
8/7/2019 First Presentation of M.Pharm
16/34
Step 1: D isruption of cell walls by grinding
Step 2: Lysis of cells in extraction buffer
Step 1+2: mechanical disruption andhomogenization in extraction buffer
Extraction/Precipitation Method
Grind sample into a fine powder to
shear cell walls and membranes
Mix thoroughly with extractionbuffer to dissolve cell membranesand inhibit nuclease activity
A homogenizer allows cells to bemechanically disrupted within theextraction buffer
rude lysate
8/7/2019 First Presentation of M.Pharm
17/34
Purposes of the Extraction Buffer1.D issolve cellular membranes2. Inactivation of D Nase and RNase3. Assist in the removal of contaminants
D etergents
Chaotropic saltsMetal chelatorsSaltsReducing agentsCTABPVP
Extraction/Precipitation Method
+
Plasma membrane(phospholipid bilayer)
D etergent molecules
Use of D etergents to Lyse Cells: Like Dissolves LikeMixed micelle
SD S
8/7/2019 First Presentation of M.Pharm
18/34
Crude lysate containingnucleic acids and othercell constituents
Mix thoroughly withan equal volume of organic solvent
e.g. phenol, chloroform,or phenol:chloroform
Centrifuge
The aqueous phase contains water-soluble molecules, including nucleicacids. Proteins and lipids becometrapped in the organic phase, and arethus separated away. Insoluble plantdebris become trapped in theinterphase between the two layers
Perform additional extractions for increased purity
Collect aqueous phase
Extraction/Precipitation MethodStep 3: Organic extraction
Organic
Aqueous
Interphase
8/7/2019 First Presentation of M.Pharm
19/34
Pellet down nucleic acids. Pellet down nucleic acids. Wash pellet with 70% ethanol to removeresidual salts and other contaminants.
Pellet down nucleic acids. Wash pellet with 70% ethanol to removeresidual salts and other contaminants.D iscard ethanol and allow pellet to dry.
Af ter
Add alcohol and salt toprecipitate nucleic acidsfrom the aqueous fraction
Supernatant
Pellet
70% EtOH
D issolve pellet(H2O, TE, etc.)
Step 4: Nucleic Acid Precipitation
Extraction/Precipitation Method
Bef ore Af ter
Centrifuge Wash Centrifuge
8/7/2019 First Presentation of M.Pharm
20/34
Basic Principle
Nucleic acids within a crude lysate
are bound to a silica surface
The silica surface is washed with asolution that keeps nucleic acids bound,
but removes all other substances
The silica surface is washed with a solutionunfavorable to nucleic acid binding. The solution,
containing purified D NA and/or RNA, is recovered.
B) ADSORPTION CHROMATOGRAPHY METHOD
8/7/2019 First Presentation of M.Pharm
21/34
Step 1: Prepare crude lysate
Silica-gel m embrane
Apply tocolumn
Step 2: Adsorb to silica surface
Adsorption Chromatography Method
Centrifuge
F low through(discard)
Nucleic acids
Surface silanol groups are weakly acidic, and will repel nucleic acidsat near neutral or high pH due totheir negative charge
Extraction Buffer composition favorsD NA and RNA adsorption to silica:
Low pHHigh i onic strengthChaotropic salt Nucleic acids bind to the membrane,
while contaminants pass through thecolumn.
8/7/2019 First Presentation of M.Pharm
22/34
Centrifuge
Nucleic acids
Step 3: Wash away residual contaminants
Adsorption Chromatography Method
Wash buffer
Nucleic acids
F low through(discard)
Nucleic acids
Elution buffer
Elution Buffer composition isunfavorable to surface binding:H igh p H Low ionic strength
Step 4: Elute nucleic acids
Centrifuge
Nucleic acids
8/7/2019 First Presentation of M.Pharm
23/34
Using Nucleases to Remove Unwanted D NA or RNA
Add D Nase
Add RNase
+ D Nase (protein)
+ RNase (protein)
D epending on when nuclease treatment is performed, it may be necessary torepeat purification steps for protein removal (e.g. phenol/chloroform extraction).
8/7/2019 First Presentation of M.Pharm
24/34
App lica tions of Isol a ted DNAy After D NA is extracted, it is used as a template in
further molecular techniques such as
y PCR (polymerase chain reaction) :- Technique for generatinglarge quantities of a specified D NA.
y R F LP (restriction fragment length polymorphism)
y Southern Blotting:-Identification of desired D NA fromthousands of molecules.
8/7/2019 First Presentation of M.Pharm
25/34
y The problem(s) with RNA:
y RNA is chemically unstable -- spontaneous cleavage of phosphodiester backbone via intramolecular transesterification
y RNA is susceptible to nearly ubiquitous RNA-degrading enzymes(RNases)
y
RNases are released upon cell lysisy RNases are present on the skiny RNases are very difficult to inactivatey -- disulfide bridges conferring stability y -- no requirement for divalent cations for activity
3 . S
e p a ra tion of RNA from cellul a r com p a rtment
8/7/2019 First Presentation of M.Pharm
26/34
Common sources of RNase and how to avoid them
Contaminated solutions/buffers
USE GOOD STERILE TECHNIQUETREAT SOLUTIONS WITH D EPC (when possible)MAKE SMALL BATCHES OF SOLUTIONS
Contaminated equipment
USE RNA-ONLY PIPETS, GLASSWARE, GEL RIGSBAKE GLASSWARE, 300C, 4 hoursUSE RNase-free PIPET TIPSTREAT EQUIPMENT WITH D EPC
3 . S e p a ra tion of RNA from cellul a r com p a rtment(Cont )
8/7/2019 First Presentation of M.Pharm
27/34
Top 10 sources of RNAse contamination(Ambion Scientific website)
1) Ungloved hands2) Tips and tubes3) Water and buffers4) Lab surfaces5) Endogenous cellular RNAses6) RNA samples
7) Plasmid preps8) RNA storage (slow action of small amounts of RNAse9) Chemical nucleases (Mg++, Ca++ at 80C for 5 +)10) Enzyme preparations
3 . S e p a ra tion of RNA from cellul a r com p a rtment(Cont )
8/7/2019 First Presentation of M.Pharm
28/34
Inhibitors of Rnase
D EPC: diethylpyrocarbonate
alkylating agent, modifying proteins and nucleic acids
fill glassware with 0.1% D EPC, let stand overnight at room temp
solutions may be treated with D EPC -- add D EPC to 0.1%, then autoclave(D EPC breaks down to CO2 and ethanol)
3 . S e p a ra tion of RNA from cellul a r com p a rtment(Cont )
8/7/2019 First Presentation of M.Pharm
29/34
Inhibitors of Rnase
Vanadyl ribonucleoside complexescompetitive inhibitors of RNAses,but need to be removed from the final preparation of RNA
Protein inhibitors of RNAse:-horseshoe-shaped, leucine rich protein,found in cytoplasm of most mammalian tissuesmust be replenished following phenol extraction steps
3 . S e p a ra tion of RNA from cellul a r com p a rtment(Cont )
8/7/2019 First Presentation of M.Pharm
30/34
y Break the cells/solubilize components/inactivate RNAsesby the addition of guanidinium thiocyanate (very powerfuldenaturant)
y Extract RNA using phenol/chloroform (at low pH)
y Precipitate the RNA using ethanol/LiCl
y Store RNA:1. in D EPC-treated H 20 (-80C)2. in formamide (deionized) at -20C
3 . S e p a ra tion of RNA from cellul a r com p a rtment(Cont )
8/7/2019 First Presentation of M.Pharm
31/34
y The purification of mRNA can be achived by affinity
chromatography using oligo(dT)-cellulose.y This is based on the principle that oligo(dT)-cellulose can
specifically bind to the poly(A) tails of eukaryotic mRNA.y Thus , by this approach, it is possible to isolate mRNA from
D NA, rRNA and tRNA.
4 . S elective se p a ra tion of mRNA from cellul a r
com p a rtment
8/7/2019 First Presentation of M.Pharm
32/34
y As nucleic acid solution is passed through an affinity chromatography column, the oligo(dT) binds to poly(A) tails of
mRNA.y By washing the column with high-salt buffer , D NA, rRNA and
tRNA can be eluted, While the mRNA is tightly bound .y This mRNA can be eluted by washing with low salt buffer.y The mRNA is precipitated with ethanol and collected by
centrifugation.
4 . S elective se p a ra tion of mRNA from cellul a r
com p a rtment(Cont . )
8/7/2019 First Presentation of M.Pharm
33/34
References :-1 . Dr. Satyanaran U. and Dr. Chakrapani U. Biochemistry
, 2 nd edition , Chapter 24 to 27, Page no.523 to 578.
2. Dr. Vyas S. P. and Dr. Dixit V. K. PharmaceuticalBiotechnology CBS Publisher & Distributors, NewDelhi, 1 st edition, Chapter 10 , Page no. 34 1 to 4 00 .
3. Ambion Scientific Website.
8/7/2019 First Presentation of M.Pharm
34/34